Learn More

 

November 12, 2026 | Volume XVII | Issue 46

Hospitals write off $132 billion

Healthcare Dive reports:


Hospitals collectively lost an estimated $132 billion last year due to write-offs for bad debt and final claim denials, according to a new report from revenue cycle analytics company Kodiak Solutions.


Revenue leakage was up by nearly 18% compared to 2024, as hospitals continued to see write-offs take up about 10 percent of net revenue last year, the analysis of Kodiak’s proprietary data showed.


This increase comes in the face of rising revenue cycle technology budgets, with more AI tools coming to market promising to improve hospitals’ financial performance, Kodiak executives said.

Read More

Bird flu is raging on a mink farm

Nat Lash, ProPublica, and Julie Leopo for ProPublica


The strain of bird flu that’s ripped through American barns for the last four years has killed two people who caught it from sick animals. But as far as anyone can tell, humans can’t spread it. The virus has remained a true “bird” flu, tailored to attach to avian cells, not invade human throats and noses, where coughing and sneezing reliably spew droplets.


Under the right conditions, however, that could change. A single mutation could give the bird flu a foothold in people and spark a pandemic that experts fear could be deadlier than COVID-19.


For that to happen, this bird flu would likely need to find an intermediate host — an animal vulnerable to viruses that infect both birds and humans. These animals would be crowded together, each infection raising the odds that a new strain could arise through mutation. Then, for that strain to jump across species, it would have to have access to humans and time to spread among them undetected.


That perfect petri dish exists right now, a ProPublica investigation found. For over two months, an outbreak of bird flu has raged uncontrolled on a Utah farm that raises thousands of mink for fur. Mink have lungs and airways that on a cellular level are remarkably...

Read More

Chronic pain management needs more than a pain score

Kayvan Haddadan, MD writes for KevinMD:


Pain relief is rarely just about lowering a number on a 0-10 scale. It is the practical restoration of daily life: being able to walk the dog without stopping every block, sleep through the night, play with grandchildren, return to work or hobbies, sit through a movie, or simply feel like themselves again. Pain reduction becomes meaningful only when it translates into regained function, energy, sleep, and participation. 

Read More

FDA orders new warning on Ozempic, Wegovy, other GLP-1 drugs over rare eye condition

ABC News


The U.S. Food and Drug Administration (FDA) has ordered manufacturers of all GLP-1 receptor agonist medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—to update their safety labels with a warning about a rare eye condition called nonarteritic anterior ischemic optic neuropathy (NAION).

Watch the video HERE.


Inside

FloridaHealthIndustry.com

Focus

Compliance Update

Best Practices

Healthcare Headlines

Game Changers

Last Word

 
Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers